Tirzepatide microdose · dual-pathway entry
Take Your Free AssessmentNo charge will be made until a licensed physician determines this treatment is right for you.
For adult consumers 18+ only
Tirzepatide is the first dual GIP/GLP-1 receptor agonist, designed to activate two hormonal systems involved in appetite, metabolism, and energy balance simultaneously. This microdose tier is a gentle introduction. Your clinician determines your dose and titration based on your individual response, labs, and goals.
RestorLife Med does not manufacture compounded medications. Actual product appearance and labeling of the medication you receive may differ from website images.
Medications are compounded by a state-licensed pharmacy. Treatment plans, including dosing and titration, are guided by your clinician. Prescription is subject to medical approval. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy. Pricing shown is introductory and subject to change. Individual results vary.